SOURCE: Prologue Research

Prologue Research

January 07, 2010 12:15 ET

Prologue People News: Art Ziegler Joins Prologue as the New VP, Business Development

COLUMBUS, OH--(Marketwire - January 7, 2010) - Prologue is pleased to announce the arrival of our new Vice President of Business Development. Art Ziegler brings with him 25 years of clinical research and business development experience. As Vice President of Business Development, his primary roles will include securing levels of sustainable, profitable revenue necessary to meet the company's financial objectives through effective sales and marketing strategies, developing and implementing marketing and sales initiatives to create awareness and demand for Prologue services within the oncology clinical research community and identifying, and meeting key decision makers of potential clients.

Prior to joining Prologue, Mr. Ziegler held various positions at Pharmaceutical (Smithkline & French Laboratories), Biotech (Ortho Biotech - JNJ), SMO (Florida Pharmaceutical Research) and CRO (Premier Research) companies. Prologue wholeheartedly welcomes him to the team and looks forward to his guidance as we continue to grow as "The Oncology CRO."

Prologue Research is a leading global oncology contract research organization (CRO) founded in 1998. The Company offers a full range of clinical research services for Phase I-IV international or US-based clinical trials in oncology. Prologue provides its clients with world-class experience, a deeply qualified staff, and state-of-the-art systems uniquely designed for complicated oncology trials. We offer the expertise, service and talent that enables our sponsors to make an impact in the lives of people with cancer.

For more information about this appointment or to learn more about Prologue's full range of oncology clinical trial services, please visit our website at or email

Contact Information

  • Contact:
    Dr. Andrew Zupnick
    Phone: 614.324.1500
    Email: Email Contact